Outset Medical (NASDAQ:OM – Get Rating) and Vivani Medical (NASDAQ:VANI – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, analyst recommendations and dividends.
Profitability
This table compares Outset Medical and Vivani Medical's net margins, return on equity and return on assets.
Get
Outset Medical alerts:
| Net Margins | Return on Equity | Return on Assets |
| Outset Medical | -145.93% | -49.75% | -39.16% |
| Vivani Medical | N/A | -8.27% | -7.86% |
Analyst Ratings
This is a summary of current ratings for Outset Medical and Vivani Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
| Outset Medical | 0 | 1 | 4 | 0 | 2.80 |
| Vivani Medical | 0 | 0 | 1 | 0 | 3.00 |
Outset Medical currently has a consensus price target of $24.50, indicating a potential downside of 9.46%. Vivani Medical has a consensus price target of $7.00, indicating a potential upside of 478.51%. Given Vivani Medical's stronger consensus rating and higher probable upside, analysts plainly believe Vivani Medical is more favorable than Outset Medical.
Institutional & Insider Ownership
98.8% of Outset Medical shares are owned by institutional investors. 4.0% of Outset Medical shares are owned by insiders. Comparatively, 47.2% of Vivani Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Outset Medical and Vivani Medical's revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
| Outset Medical | $102.60 million | 12.74 | -$131.93 million | ($3.42) | -7.91 |
| Vivani Medical | N/A | N/A | -$8.92 million | N/A | N/A |
Vivani Medical has lower revenue, but higher earnings than Outset Medical.
Risk & Volatility
Outset Medical has a beta of 1.49, suggesting that its stock price is 49% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.54, suggesting that its stock price is 154% more volatile than the S&P 500.
Summary
Vivani Medical beats Outset Medical on 8 of the 11 factors compared between the two stocks.
About Outset Medical
(Get Rating)
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
About Vivani Medical
(Get Rating)
Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.
Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.
